Navigation Links
Omeros Corporation Reports First Quarter 2013 Financial Results
Date:5/10/2013

nfertility.

About Omeros Corporation
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The Company's most clinically advanced product candidates, OMS302 for lens replacement surgery and OMS103HP for arthroscopy, are derived from its proprietary PharmacoSurgery™ platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has five clinical development programs. Omeros may also have the near-term capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of protein and small-molecule preclinical programs targeting inflammation, coagulopathies and central nervous system disorders.

Forward-Looking Statements
This press release contains forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995, which are subject to the "safe harbor" created by those sections. These statements include, but are not limited to, Omeros' expectations regarding the closing date of the public offering; the submission dates for the OMS302 New Drug Application and Marketing Authorization Application; when it will be able to market and sell OMS302; when it will commence clinical trials for its MASP-2 and PDE7; the potential benefits of its potential products; and its capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Forward-looking statements are based on management's beliefs and assumptions and on information available to management only as of the date of this press release. Omeros' actual results could differ materially from those anticipated in these forward-looking statements for
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Omeros Announces $16.2 Million Registered Direct Offering of Common Stock
2. Omeros Ophthalmology Product OMS302 Granted Eligibility for European Centralized Review
3. Omeros to Present Additional OMS302 Clinical Data at the Annual ASCRS and ASOA Symposium and Congress
4. Omeros Files Orphan Drug Application for Treatment of Atypical Hemolytic Uremic Syndrome with OMS721
5. Omeros Announces that GPR17 Antagonists Improve Function in Model of Multiple Sclerosis
6. Omeros Announces Positive OMS721 Data in Model of Thrombotic Microangiopathy
7. Omeros to Present at the 2013 Future Leaders in the Biotech Industry Conference
8. Omeros Announces Toxicology Data that Support Advancing MASP-2 Inhibitor into Clinical Trials
9. Omeros Announces Successful Completion of PDE10 Phase 1 Multiple Ascending Dose Trial
10. Omeros Elucidates Mechanism of its PDE7 Inhibitors in Addiction
11. Omeros to Present at the Cowen and Company 33rd Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... TRIANGLE PARK, N.C. , July 31, 2014 /PRNewswire/ ... Miami facilities to meet the clinical ... America .  The newly expanded facility will continue ... samples, consolidation of shipments to and from the region, ... In its newest location, Marken will combine its office ...
(Date:7/31/2014)... De Pfizer Clinical Research Unit (PCRU) heeft de lancering ... komaf voor medewerking aan klinisch onderzoek. De in ... twee onderzoekseenheden van Pfizer , een multinationaal farmaceutisch ... ontdekking en ontwikkeling van nieuwe medicijnen. Om onderzoeksprojecten te ... vrouwen van Japanse komaf – leeftijd 18 tot 55 ...
(Date:7/30/2014)... July 30, 2014  Cepheid (Nasdaq: ... contract with Premier will end on September 30, ... will be able to continue their relationship with ... MedAssets, Novation, and ROi, in addition to the ... Cepheid. "Cepheid has always recognized and ...
Breaking Medicine Technology:Marken Expands Miami Regional Logistics Center 2Gezonde vrijwilligers van Japanse komaf gezocht voor deelname aan Fase I klinisch onderzoek 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 3
... Thousands of,research studies have documented how the ... cardiovascular system, particularly among people diagnosed,with coronary artery ... creates difficulty for many physicians and patients to ... oils., In the March issue of Mayo ...
... Accell siRNA Simplifies Delivery to Cells and Significantly ... Effectiveness of RNAi in Key Life Sciences Applications, ... Inc. (NYSE: TMO ), the world leader ... that greatly simplifies RNA-,interference (RNAi) technology and eliminates ...
Cached Medicine Technology:Mayo Clinic Proceedings Contributors Highlight Research Findings About Cardiovascular Benefits Associated With Omega-3 Fatty Acids 2Mayo Clinic Proceedings Contributors Highlight Research Findings About Cardiovascular Benefits Associated With Omega-3 Fatty Acids 3Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology 2Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology 3
(Date:7/31/2014)... Healthpointe Medical Group, one of ... the highest standards in health and safety for ... offering Occupational Medicine Services at their ... They also accept workers’ compensation cases and referrals ... services include, but are not limited to, return-to-work ...
(Date:7/31/2014)... July 31, 2014 Healthinsurancefacts.org has ... affordable health insurance plans by comparing quotes. , ... plans, clients should consider comparing quotes. They can do ... completing a simple questionnaire. , Clients should do ... several individual health insurance policies, and each of them ...
(Date:7/31/2014)... Dallas Fit Body Boot Camp ... 3821 Ross Avenue, also in Dallas, in an effort to ... to burn fat and get in great shape fast. , ... believes that the new space will help his current members ... want as well as accommodate new members interested in joining ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 The ... first-ever event in New York on Thursday, August 7, ... Manhattan. , Featuring keynotes by State Senator Diane ... (R-Yorktown), the event will include lunch and in-depth discussions ... and the work NCIA is doing federally to advance ...
(Date:7/31/2014)... With a busy lifestyle, it is hard to relax. World ... but to ensure their mental health is equally in check. ... right is key to your body’s health. However, I want everyone ... healthy lifestyle,” expressed Chef Ravi, owner of World Gardens Cafe. Check ... , ", 1. Stop eating lunch at your desk or taking ...
Breaking Medicine News(10 mins):Health News:Occupational Medicine Services Available at Healthpointe’s Perris Facility 2Health News:Comparing Health Insurance Quotes Can Help Clients Find Affordable Plans 2Health News:Dallas Fit Body Boot Camp Moves to New Location, Announces Grand Opening Set for Saturday August 9th 2Health News:THURSDAY, AUG 7: First-Ever National Cannabis Industry Association Event in New York Will Feature Senator Savino, Assemblyman Katz, & Industry Leaders 2Health News:World Garden’s Cafe Launches ‘16 Simple Ways to Feel Connected to the World’ 2Health News:World Garden’s Cafe Launches ‘16 Simple Ways to Feel Connected to the World’ 3Health News:World Garden’s Cafe Launches ‘16 Simple Ways to Feel Connected to the World’ 4
... Calif., Feb. 27 Nationwide,Health Properties, Inc. (NYSE: ... M. Pasquale and Chief Financial and Portfolio,Officer, Abdo H. ... Property CEO Conference hosted by Citigroup at The Breakers ... at 9:45 am (EST)., The presentation can be ...
... Researchers at The Scripps Research Institute have developed a ... successfully tested aspects of it in the laboratory. , ... Early Edition of the Proceedings of the National Academy ... preventive/therapeutic vaccine against HIV, say the authors. To date, ...
... ... System ... 27 In the face of what they,describe as a "hostile" bargaining attitude by ... this week,and next on whether to authorize their bargaining teams to strike the,hospital chain ...
... CHAPEL HILL, N.C., Feb. 27 Effective communication ... compound into a,blockbuster brand. How, when, and to ... delivered -- these are some of the key ... Best Practices in Communicating,Clinical Trial Results." -- A ...
... Nancy Pelosi,House Majority Leader Steny Hoyer and House ... the appointment of Retired Master,Gunnery Sergeant Patricia Orsini ... new Wounded Warrior Program., The Wounded Warrior ... Leader Hoyer and Chairman Brady with the goal ...
... to health care might help to overcome racial and ethnic ... the March 2008 issue of Clinical Journal of the American ... "yet another wake-up call as to how we as a ... nation, including the reduction and/or elimination of health disparities," according ...
Cached Medicine News:Health News:Nationwide to Present at Citigroup Global Property CEO Conference 2Health News:Nationwide to Present at Citigroup Global Property CEO Conference 3Health News:Scripps research scientists devise approach that stops HIV at earliest stage of infection 2Health News:Scripps research scientists devise approach that stops HIV at earliest stage of infection 3Health News:5,000 Northern California Nurses to Vote to Authorize Third Strike Against Sutter Chain 2Health News:5,000 Northern California Nurses to Vote to Authorize Third Strike Against Sutter Chain 3Health News:Communicating Clinical Trial Data: Timing Remains Key Challenge for Marketing Teams 2Health News:Pelosi, Hoyer, Brady Announce Appointment of Director of House Wounded Warrior Program 2Health News:Pelosi, Hoyer, Brady Announce Appointment of Director of House Wounded Warrior Program 3Health News:Race, insurance status affect access to transplantation and kidney disease treatment 2Health News:Race, insurance status affect access to transplantation and kidney disease treatment 3
... a web-based application to securely access patient ... Users can login from virtually anywhere ... review stored patient studies. , ... images, and reports Quickly locates desired patient ...
... for Stainless Steel Kleener. SSK-80 is our ... stain remover for ultra-sonic cleaners. , ,Used ... your instruments by removing and inhibiting rust, ... points, box joints and moving instrument parts ...
... the ready-to-use, pre-cleaning enzymatic foam for use ... ,Hemaway Enzymatic Foam sprays on surgical instruments ... for use in the O.R. or when ... head start with Hemaway Enzymatic Foam can ...
... The Shandon Cytospin has been ... 35 years. More than 15,000 ... reliable instrument. It provides economical ... matrix, especially hypocellular fluids such ...
Medicine Products: